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Fig. S1: OPTIMA targets for additional patients .................................................................................... 3 Fig. S2 : Clinical ablation lesions from : RA ablation lesions from Table S1 : Clinical characteristics and chamber measurements for all OPTIMA patients ...................... 5 Table S2 : Table S3 : Clinical outcomes for Captions LGE-MRI scans, including the distribution of fibrotic tissue. For patient 2, only the right atrial (RA) posterior view is shown since that was the only location where an RD was observed in simulations; otherwise, the views shown are posterior (top) and anterior (bottom). b, Example activation sequences during arrhythmia morphologies induced following the rapid pacing protocol, and the corresponding persistent reentrant drivers (RDs, pink) obtained from the analysis of the induced arrhythmias. c, If applicable, activation sequences associated with arrhythmia emerging anew in the models following virtual ablation (lesions shown in orange), and the corresponding emergent RDs (pink); For Patient 10, the left atrial outline is shown in silhouette to facilitate visualization of an RD on the posterior aspect of the superior vena cava. d, Custom-tailored OPTIMA ablation treatment plans, including targets corresponding to all RDs (pre-ablation and emergent) and lesion lines connecting the latter to nonconductive tissue boundaries. 66±7 9(90%) 30±5 24.1±12.4 18.6±14.2 51.5±20 47.5±14.6 2[1;2] 1[0;1 
